CN105031227A - Traditional Chinese medicine for treating myopia - Google Patents
Traditional Chinese medicine for treating myopia Download PDFInfo
- Publication number
- CN105031227A CN105031227A CN201510577807.6A CN201510577807A CN105031227A CN 105031227 A CN105031227 A CN 105031227A CN 201510577807 A CN201510577807 A CN 201510577807A CN 105031227 A CN105031227 A CN 105031227A
- Authority
- CN
- China
- Prior art keywords
- myopia
- chinese medicine
- parts
- fructus
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses traditional Chinese medicine for treating myopia. The traditional Chinese medicine for treating the myopia comprises, by weight, 10-20 parts of radix rehmanniae, 3-7 parts of glossy privet fruits, 3-7 parts of mulberries, 20-40 parts of barbary wolfberry fruits, 3-7 parts of cornus officinalis, 30-40 parts of concha haliotidis, 3-7 parts of schisandra chinensis and 3-7 parts of radix ophiopogonis. The traditional Chinese medicine for treating the myopia is good in myopia treatment effect, wide in usage crowd and capable of effectively relieving and treating the myopia symptoms.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly relate to a kind of Chinese medicine for the treatment of myopia.
Background technology
Chinese medicine (Chineseherbology, TraditionalMateriaMedica), refers under tcm theory instructs for preventing, diagnosing, treat or regulate the medicine of function of human body.Chinese medicine is divided into Chinese patent medicine, Chinese crude drug by processing technique.Chinese medicine is originating primarily from China, except plant amedica, animal drugs as Fel Serpentis, Fel Ursi, Agkistrodon, Cornu Cervi Pantotrichum, Cornu Cervi etc.; Shell class as Margarita, Concha Meretricis seu Cyclinae; Mineral substance is as Os Draconis, and Magnetitum etc. are all used to the Chinese medicine of curing the disease.
Myopia, names of disease of tcm.Be that eye is regulating under relaxed state, parallel rays is before the refraction back focus of the dioptric system of eye drops on retina.Ancient medical book is early recognized primary disease, is called that order can not hypermetropia, and having another name called can nearly timid disease far away, begins to claim myopia to " order is through great achievement ".By congenital generation, myopic degree the higher person is also known as myopia.The generation of myopia with hereditary, grow, the factors such as environment is relevant, but definite pathogeny is still under study for action.
Dialectical main points: insufficiency of vital energy and blood is demonstrate,proved, watching for a long time hematozemia, blood being the material foundation of QI, and blood deficiency gas is also empty, God Light can not be sent out more at a distance, dialectical with mistake eyesight, distant vision being blurred for main points.Liver and kidney two deficiency syndrome, innate deficiency, sun declined cloudy so that brilliance can not far and, therefore depending near and can not look far.Dialectical with distant vision being blurred since the childhood for main points.
Summary of the invention
For the deficiencies in the prior art, technical problem to be solved by this invention is to provide a kind of Chinese medicine for the treatment of myopia.
Technical problem of the present invention is implemented by following technical proposals:
Treat myopia a Chinese medicine, comprise following weight parts raw material: Radix Rehmanniae 10-20 part, Fructus Ligustri Lucidi 3-7 part, Fructus Mori 3-7 part, Fructus Lycii 20-40 part, Fructus Corni 3-7 part, Concha Haliotidis 30-40 part, Fructus Schisandrae Chinensis 3-7 part, Radix Ophiopogonis 3-7 part.
Preferably,
Treat myopia a Chinese medicine, comprise following weight parts raw material: Radix Rehmanniae 10-20 part, Fructus Ligustri Lucidi 3-7 part, Fructus Mori 3-7 part, Fructus Lycii 20-40 part, Fructus Corni 3-7 part, Concha Haliotidis 30-40 part, Fructus Schisandrae Chinensis 3-7 part, Radix Ophiopogonis 3-7 part, plant antistaling agent 0.2-0.6 part.
Described plant antistaling agent is deoxyschizandrin and/or schisandrin C.
Described plant antistaling agent is made up of 30-70wt% deoxyschizandrin and 30-70wt% schisandrin C.
Each raw material pulverizing is uniformly mixed, the Chinese medicine for the treatment of myopia of the present invention can be obtained.
The Chinese medicine for the treatment of myopia of the present invention, better to the therapeutic effect of myopia, use crowd comparatively wide, can effectively alleviate myopia symptoms and treat.After interpolation plant antistaling agent, more easily preserve.
Detailed description of the invention
Embodiment 1-6
Each raw material pulverizing is uniformly mixed, pouch-packaged, 3 grams every bag, the Chinese medicine for the treatment of myopia of the present invention can be obtained.
Table 1: the Chinese medicine formula list position for the treatment of myopia: gram
| Raw material | Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | Embodiment 5 | Embodiment 6 |
| The Radix Rehmanniae | 15 | 15 | 15 | 15 | 15 | 15 |
| Fructus Ligustri Lucidi | 5 | 5 | 5 | 5 | 5 | 5 |
| Fructus Mori | 5 | 5 | 5 | 5 | 5 | 5 |
| Fructus Lycii | 30 | 30 | 30 | 30 | 30 | 30 |
| Fructus Corni | 5 | 5 | 5 | 5 | 5 | 5 |
| Concha Haliotidis | 35 | 35 | 35 | 35 | 35 | 35 |
| Fructus Schisandrae Chinensis | 5 | 5 | 5 | 5 | 5 | 5 |
| Radix Ophiopogonis | 5 | 5 | 5 | 5 | 5 | 5 |
| Deoxyschizandrin | 0.2 | 0.4 | - | - | 0.2 | - |
| Schisandrin C | 0.2 | - | 0.4 | - | - | 0.2 |
| Schisandrin B | - | - | - | 0.4 | 0.2 | 0.2 |
Deoxyschizandrin, No. CAS: 61281-38-7.Schisandrin B, No. CAS: 61281-37-6.Schisandrin C, No. CAS: 61301-33-5.
Deoxyschizandrin, schisandrin C not only have preservation and antisepsis effect, effectively can also improve asthenopia, and its successful is better than schisandrin B.
The Chinese medicine for the treatment of myopia of the present invention, better to the therapeutic effect of myopia, use crowd comparatively wide, can effectively alleviate myopia symptoms and treat.
Test case
Test mixed liquor prepared by embodiment 1-6, room temperature 25 DEG C is also stored open under gravity-flow ventilation condition, and sampling and testing after 10 days, measures total plate count under the microscope.Result is as shown in table 2.
Table 2: total plate count test chart
| Total plate count, cfu/g | |
| Embodiment 1 | 2.6×10 4 |
| Embodiment 2 | 4.8×10 4 |
| Embodiment 3 | 4.5×10 4 |
| Embodiment 4 | 8.1×10 4 |
| Embodiment 5 | 6.3×10 4 |
| Embodiment 6 | 6.6×10 4 |
After interpolation plant antistaling agent, total plate count obviously declines, and shelf life of products is significantly extended.
Case:
1, Zhang, man, 18 years old, before taking medicine, myopic degree was: naked vision is 0.4, took the Chinese medicine of the treatment myopia of embodiment 1 of the present invention, and twice daily, each 3 grams, after one week, effectively alleviate myopia symptoms, after two weeks, naked vision rises to 0.7.
2, Liu, female, 16 years old, before taking medicine, myopic degree was: naked vision is 0.5, took the Chinese medicine of the treatment myopia of embodiment 1 of the present invention, and twice daily, each 3 grams, after two weeks, effectively alleviate myopia symptoms, after January, naked vision rises to 0.8.
Claims (2)
1. treat myopia a Chinese medicine, comprise following weight parts raw material: Radix Rehmanniae 10-20 part, Fructus Ligustri Lucidi 3-7 part, Fructus Mori 3-7 part, Fructus Lycii 20-40 part, Fructus Corni 3-7 part, Concha Haliotidis 30-40 part, Fructus Schisandrae Chinensis 3-7 part, Radix Ophiopogonis 3-7 part.
2. treat myopia a Chinese medicine, comprise following weight parts raw material: Radix Rehmanniae 10-20 part, Fructus Ligustri Lucidi 3-7 part, Fructus Mori 3-7 part, Fructus Lycii 20-40 part, Fructus Corni 3-7 part, Concha Haliotidis 30-40 part, Fructus Schisandrae Chinensis 3-7 part, Radix Ophiopogonis 3-7 part, plant antistaling agent 0.2-0.6 part;
Described plant antistaling agent is made up of 30-70wt% deoxyschizandrin and 30-70wt% schisandrin C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510577807.6A CN105031227A (en) | 2015-09-11 | 2015-09-11 | Traditional Chinese medicine for treating myopia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510577807.6A CN105031227A (en) | 2015-09-11 | 2015-09-11 | Traditional Chinese medicine for treating myopia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105031227A true CN105031227A (en) | 2015-11-11 |
Family
ID=54438587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510577807.6A Pending CN105031227A (en) | 2015-09-11 | 2015-09-11 | Traditional Chinese medicine for treating myopia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105031227A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1269222A (en) * | 1999-04-02 | 2000-10-11 | 冯朝甫 | Myopia treating medicine |
| CN103211969A (en) * | 2013-03-25 | 2013-07-24 | 张新英 | Traditional Chinese medicine for treatment of myopia |
| CN104689107A (en) * | 2015-02-10 | 2015-06-10 | 潘雄峰 | Traditional Chinese medicine for treating nearsightedness and preparation method thereof |
| CN104815099A (en) * | 2015-04-28 | 2015-08-05 | 广西大学 | Traditional Chinese medicine preparation for treating nearsightedness of teenagers |
| CN104824510A (en) * | 2015-05-13 | 2015-08-12 | 宁波北仑戌鸿农业科技有限公司 | Health food with eyesight protection function |
-
2015
- 2015-09-11 CN CN201510577807.6A patent/CN105031227A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1269222A (en) * | 1999-04-02 | 2000-10-11 | 冯朝甫 | Myopia treating medicine |
| CN103211969A (en) * | 2013-03-25 | 2013-07-24 | 张新英 | Traditional Chinese medicine for treatment of myopia |
| CN104689107A (en) * | 2015-02-10 | 2015-06-10 | 潘雄峰 | Traditional Chinese medicine for treating nearsightedness and preparation method thereof |
| CN104815099A (en) * | 2015-04-28 | 2015-08-05 | 广西大学 | Traditional Chinese medicine preparation for treating nearsightedness of teenagers |
| CN104824510A (en) * | 2015-05-13 | 2015-08-12 | 宁波北仑戌鸿农业科技有限公司 | Health food with eyesight protection function |
Non-Patent Citations (1)
| Title |
|---|
| 张媛媛等: "五味子抑菌成分的提取及在面制食品保鲜中的应用", 《粮食与饲料工业》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104435763A (en) | Medicine for treating oculopathy | |
| CN104971304A (en) | Xerophthalmia treatment medicine | |
| CN105031227A (en) | Traditional Chinese medicine for treating myopia | |
| WO2016115768A1 (en) | Burn ointment for promoting tissue regeneration and skin growth, and preparation method therefor | |
| CN105125752A (en) | Traditional Chinese medicinal composition for treating nearsightedness | |
| CN105168320A (en) | Lutein chewable tablet | |
| CN105106589A (en) | Traditional Chinese medicine for improving eyesight | |
| CN101618162B (en) | Traditional Chinese medicine for treating viral keratitis | |
| Ahmadi et al. | Comparison of graft survival between fat harvested from abdomen and medial thigh for facial contour deformity: a randomised control trial | |
| CN105169177A (en) | Traditional Chinese medicinal preparation for treating visual fatigue, teenage amblyopia, pseudomyopia and myopia | |
| CN104784482A (en) | Traditional Chinese medicine for treating chronic pyogenic osteomyelitis | |
| CN100348259C (en) | Medicine composition for raising immunity and its prepn and application | |
| CN103099977B (en) | Externally used drug composition for ophthalmology department and application of externally used drug composition in application of treatment of uveitis | |
| CN104306912A (en) | Traditional Chinese medicine used for treating meniere disease | |
| CN105106355A (en) | Chewable tablets for improving eyesight | |
| 이경호 et al. | The effects of part-time occlusion therapy shortened to one or two hours in intermittent exotropia | |
| CN106620372A (en) | Traditional Chinese medicine composition used for treating leukemia | |
| TWI556825B (en) | A variety of natural plant extracts to relieve acid and pain and its preparation method | |
| CN105250394A (en) | Traditional Chinese medicine composition for treating cataract and preparation method and application thereof | |
| CN104398719B (en) | Traditional Chinese medicine composition for treating edema and preparation method thereof | |
| CN104800385A (en) | Traditional Chinese medicine for treating recurrent erysipelas | |
| CN105362924A (en) | Traditional Chinese medicine composition for treating female amenorrhea | |
| CN108404052A (en) | Prevention myopia, the pharmaceutical composition and the preparation method and application thereof of amblyopia | |
| Angadi et al. | Role of Lekhana Anjana and Abhyantara Oushadi in the Management of Kaphaja Kacha wsr to Senile Immature Cataract | |
| CN104367762B (en) | A kind of Chinese medicine preparation for treating yang deficiency of spleen and stomache optic atrophy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151111 |